Moloney murine leukemia virus activates NF-κB

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 4167-4172

  Pak, John ^a   Faller, Douglas V ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; ENHANCER REGION; GENE ACTIVATION; GENE INSERTION; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; VIRUS CARCINOGENESIS;

EID: 0029970933     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.6.4167-4172.1996     Document Type: Article

References (64)

1. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
2. Bachelerie, F., J. Alcami, F. Arenzana-Seisdedos, and J. L. Virelizier. 1991. HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes. Nature (London) 350:709-712.
3. Baeuerle, P. A. 1991. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072:63-80.
4. Ballard, D. W., E. Bohnlein, J. W. Lowenthal, V. Wano, B. R. Franza, and W. C. Greene. 1988. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science 241:1652-1655.
5. Beg, A. A., and A. Baldwin, Jr. 1993. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7:20642070.
6. Blank, V., P. Kourilsky, and A. Israel. 1992. NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem. Sci. 17:135-140.
7. Borellini, F., Y. F. He, A. Aquino, G. Yu, S. F. Josephs, and R. I. Glazer. 1992. Increased DNA binding and transcriptional activity associated with transcription factor Sp1 in K562 cells transfected with the myeloid-specific c-fes tyrosine kinase gene. Pharmacol. Ther. 55:303-318.
8. Böse, H., Jr. 1992. The Rel family: models for transcriptional regulation and oncogenic transformation. Biochim. Biophys. Acta 1114:1-17.
9. Bours, V., G. Franzoso, K. Brown, S. Park, V. Azarenko, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist. 1992. Lymphocyte activation and the family of NF-kappa B transcription factor complexes. Curr. Top. Microbiol. Immunol. 182:411-420.
10. Brightman, B. K., B. R. Davis, and H. Fan. 1990. Preleukemic hematopoietic hyperplasia induced by Moloncy murine leukemia virus is an indirect consequence of viral infection. J. Virol. 64:4582-4584.
11. Browned, E., N. Mittereder, and N. R. Rice. 1989. A human rel protooncogene cDNA containing an Alu fragment as a potential coding exon. Oncogene 4:935-942.
12. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
13. Cherrington, J. M., and E. S. Mocarski. 1989. Human cytomegalovirus ie1 transactivates the a promoter-enhancer via an 18-base-pair repeat element. J. Virol. 63:1435-1440.
14. Chumakov, I., H. Stuhlmann, K. Harbers, and R. Jaenisch. 1982. Cloning of two genetically transmitted Moloney leukemia proviral genomes: correlation between biological activity of the cloned DNA and viral genome activation in the animal. J. Virol. 42:1088-1098.
15. Conant, K., W. J. Atwood, R. Traub, C. Tornatore, and E. O. Major. 1994. An increase in p50/p65 NF-κB binding to the HIV-1 LTR is not sufficient to increase viral expression in the primary human astrocyte. Virology 205:586590.
16. Cordle, S. R., R. Donald, M. A. Read, and J. Hawiger. 1993. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells. J. Biol. Chem. 268:11803-11810.
17. Cuypers, H. T., G. Selten, W. Quint, M. Zijlstra, E. R. Maandag, W. Boelens, P. van Wezenbeek, C. Melief, and A. Berns. 1984. Murine leukemia virusinduced T-ccll lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell 37:141-150.
18. Davis, B. R., B. K. Brightman, K. G. Chandy, and H. Fan. 1987. Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukcmogenesis. Proc. Natl. Acad. Sci. USA 84:4875-4879.
19. Devary, Y., C. Rosette, J. A. DiDonato, and M. Karin. 1993. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 261:1442-1445.
20. Diaz-Meco, M. T., E. Berra, M. M. Municio, L. Sanz, J. Lozano, I. Dominguez, V. Diaz-Golpe, M. T. Lain de Lera, J. Alcami, C. V. Paya, F. Arenzana-Seisdedos, J.-L. Virelizier, and J. Muscat. 1993. A dominant negative protein kinase C ζ subspecies blocks NF-κB activation. Mol. Cell. Biol. 13:4770-4775.
21. Duyao, M. P., A. J. Buckler, and G. E. Sonenshein. 1990. Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. Proc. Natl. Acad. Sci. USA 87:4727-4731.
22. Faller, D. V., L. D. Wilson, and D. C. Flyer. 1988. Mechanism of induction of class I major histocompatibility antigen expression by murine leukemia virus. J. Cell. Biochem. 36:297-309.
23. Fan, C. M., and T. Maniatis. 1991. Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway. Nature (London) 354:395-398.
24. Fan, H. 1990. Influences of the long terminal repeats on retroviral pathogenicity. Semin. Virol. 1:164-174.
25. Finco, T. S., and A. Baldwin, Jr. 1993. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1. J. Biol. Chem. 268:17676-17679.
26. Flyer, D. C., S. J. Burakoff, and D. V. Faller. 1985. Expression and CTL recognition of cloned subgenomic fragments of Moloney murine leukemia virus in murine cells. Surv. Immunol. Res. 4:168-172.
27. Ghosh, S., A. M. Gifford, L. R. Rivlere, P. Tempst, G. P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. Cell 62:1019-1029.
28. Gilman, M. Z., R. N. Wilson, and R. A. Weinberg. 1986. Multiple proteinbinding sites in the 5'-flanking region regulate c-fos expression. Mol. Cell. Biol. 6:4305-4316.
29. Gilmore, T. D. 1992. Role of rel family genes in normal and malignant lymphoid cell growth. Cancer Surv. 15:69-87.
30. Gilmore, T. D., and P. J. Morin. 1993. The I kappa B proteins: members of a multifunctional family. Trends Genet. 9:427-433.
31. Godowski, P. J., D. Picard, and K. R. Yamamoto. 1988. Signal transduction and transcriptional regulation by glucocorticoid receptor-LexA fusion pro-teins. Science 241:812-816.
32. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1182. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
33. Grilli, M., J. J. Chiu, and M. J. Lenardo. 1993. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
34. Grimm, S., and P. A. Baeuerle. 1993. The inducible transcription factor NF-kappa B: structure-function relationship of its protein submits. Biochem. J. 290:297-308.
35. Hayward, W. S., B. G. Neel, and S. M. Astrin. 1981. Activation of a cellular one gene by promoter insertion in ALV-induced lymphoid leukosis. Nature (London) 290:475-480.
36. Henkel, T., U. Zabel, K. van Zee, J. M. Muller, E. Fanning, and P. A. Baeuerle. 1992. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit. Cell 68:1121-1133.
37. Inoue, J., L. D. Kerr, D. Rashid, N. Davis, H. Bose, Jr., and I. M. Verma. 1992. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc. Natl. Acad. Sci. USA 89:4333-4337.
38. Kerr, L. D., J. Inoue, N. Davis, E. Link, P. A. Baeuerle, H. Bose, Jr., and I. M. Verma. 1991. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation. Genes Dev. 5:1464-1476.
39. Kieran, M., V. Blank, F. Logeai, J. Vandekerckhove, F. Lottspeich, O. Le Bail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israel. 1990. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007-1018.
40. Koka, P., K. van de Mark, and D. V. Faller. 1991. trans-Activation of genes encoding activation-associated human T lymphocyte surface proteins by murine retroviral sequences. J. Immunol. 146:2417-2425.
41. Leung, K., and G. J. Nabel. 1988. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature (London) 333:776-778.
42. 89Sr complements a preleukemic defect in a long terminal repeat variant of Moloney murine leukemia virus. J. Virol. 65:4442-4448.
43. Li, S., and J. M. Sedivy. 1993. Raf-1 protein kinase activates the NF-kappa B transcription factor by dissociating the cytoplasmic NF-kappa B-I kappa B complex. Proc. Natl. Acad. Sci. USA 90:9247-9251.
44. Mercurio, F., J. Didonato, C. Rosette, and M. Karin. 1992. Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105. DNA Cell Biol. 11:523-537.
45. Mercurio, F., J. A. DiDonato, C. Rosette, and M. Karin. 1993. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. Genes Dev. 7:705-718.
46. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711-713. (Erratum, 344:178, 1990.)
47. Nolan, G. P., and D. Baltimore. 1992. The inhibitory ankyrin and activator Rel proteins. Curr. Opin. Genet. Dev. 2:211-220.
48. Perez, P., S. A. Lira, and R. Bravo. 1995. Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein IκBα. Mol. Cell. Biol. 15:3523-3530.
49. Renfranz, P. J., M. G. Cunningham, and R. D. McKay. 1991. Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell 66:713-729.
50. Rice, N. R., T. D. Copeland, S. Simek, S. Oroszlan, and R. V. Gilden. 1986. Detection and characterization of the protein encoded by the v-rel oncogene. Virology 149:217-229.
51. Rice, N. R., M. L. MacKichan, and A. Israel. 1992. The precursor of NFkappa B p50 has I kappa B-like functions. Cell 71:243-253.
52. Richardson, P. M., and T. D. Gilmore. 1991. vRel is an inactive member of the Rel family of transcriptional activating proteins. J. Virol. 65:3122-3130.
53. Riviere, Y., V. Blank, P. Kourilsky, and A. Israel. 1991. Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection. Nature (London) 350:625-626.
54. Ross, E. K., A. J. Buckler-White, A. B. Rabson, G. Englund, and M. A. Martin. 1991. Contribution of NF-κB and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J. Virol. 65:4350-4358.
55. Roulston, A., M. D'Addario, F. Boulerice, S. Caplan, M. A. Wainberg, and J. Hiscott. 1992. Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells. J. Exp. Med. 175:751-763.
56. Ruben, S., H. Poteat, T. H. Tan, K. Kawakami, R. Roeder, W. Haseltine, and C. A. Rosen. 1988, Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science 241:89-92.
57. Ruben, S. M., P. J. Dillon, R. Schreck, T. Henkel, C. H. Chen, M. Maher, P. A. Baeuerle, and C. A. Rosen. 1991. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. Science 251:1490-1493. (Erratum, 254:11.)
58. Ryseck, R.-P., P. Bull, M. Takamiya, V. Bours, V. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:674-684.
59. Schmid, R. M., N. D. Perkins, C. S. Duckett, P. C. Andrews, and G. J. Nabel. 1991. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65. Nature (London) 352:733-736.
60. Sen, R., and D. Baltimore. 1986. Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism. Cell 47:921-928.
61. Shen-Ong, G. L. C., and L. Wolff. 1987. Moloney murine leukemia virusinduced myeloid tumors in adult BALB/c mice: requirement of c-myb acti-vation hut lack of v-abl involvement. J. Virol. 61:3721-3725.
62. Traenckner, E. B., S. Wilk, and P. A. Baeuerle. 1994. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still hound to NF-kappa B. EMBO J. 13: 5433-5441.
63. Wilson, L. D., D. C. Flyer, and D. V. Faller. 1987. Murine retroviruses control class I major histocompatibility antigen gene expression via a trans effect at the transcriptional level. Mol. Cell. Biol. 7:2406-2415.
64. Wolff, L., J. F. Mushinski. G. L. Shen-Ong, and H. Morse. 1988. A chronic inflammatory response. Its role in supporting the development of c-myb and c-myc related promonocytic and monocytic tumors in BALB/c mice. J. Immunol. 141:681-689.